Traders Continue Buying Weakness in Teva Pharma (TEVA)

Article Related Articles (1) Stock Quotes (1) Comments (0)

Teva Pharmaceutical Industries (NYSE: TEVA) is lower on the session, but market indicators hint that many are buying the opportunity.

According to recent data, money flow for Teva is $5.46 million favoring uptick purchases. The uptick-to-downtick ratio is 1.24 times.

Shares have been hit since the middle of December, down about 13 percent over the last few weeks.

Indicators also have the pharma being oversold with the 14-bar money flow index moving below the 20 percent threshold. The last time Teva made such a move was last May.

The stock is off just 0.1 percent Monday.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Chile regulators stopped build, imposed sanctions on Barrick Gold (ABX)
• InterOil (IOC) Indicated Much Higher on ExxonMobil Negotiations
• UPDATE: Crash in American Electric Power (AEP) & NextEra Energy (NEE) Adds to Jitters

Create E-mail Alert Related Categories

Technicals, Trader Talk

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?